Despite the promising advances, several challenges remain. One major hurdle is the heterogeneity of cancer, meaning that cancers can vary greatly from one patient to another, even within the same type. This makes it difficult to develop one-size-fits-all treatments. Additionally, the high cost of research and clinical trials can limit progress. There is also a need for more comprehensive data sharing among researchers to accelerate discoveries.
